Patent details

EP2699265 Title: STABLE PHARMACEUTICAL LIQUID FORMULATIONS OF THE FUSION PROTEIN TNFR:Fc

  • Data
  • Documents

Basic Information

Publication number:
EP2699265
PCT Application Number:
EP2012057119
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127151074
PCT Publication Number:
WO2012143418
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
STABLE PHARMACEUTICAL LIQUID FORMULATIONS OF THE FUSION PROTEIN TNFR:Fc
French Title of Invention:
FORMULATIONS LIQUIDES PHARMACEUTIQUES STABLES DE LA PROTÉINE DE FUSION TNFR:FC
German Title of Invention:
STABILE PHARMAZEUTISCHE FLÜSSIGFORMULIERUNGEN DES FUSIONSPROTEINS TNFR:FC
SPC Number:

Dates

Filing date:
19/04/2012
Grant date:
16/10/2019
EP Publication Date:
26/02/2014
PCT Publication Date:
26/10/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/10/2019
EP B1 Publication Date:
16/10/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/04/2020
Expiration date:
19/04/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/10/2019
 
 

Name:
Sandoz AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
FUERTINGER, Sabine
Address:
Austria (AT)

2

Name:
LAUBER, Thomas
Address:
Austria (AT)

3

Name:
DEUTEL, Britta
Address:
Austria (AT)

Priority

Priority Number:
11163171
Priority Date:
20/04/2011
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 38/00; A61K 47/12; A61K 47/18;

Publication

European Patent Bulletin

Issue number:
201942
Publication date:
16/10/2019
Description:
Grant (B1)
Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: